Sorafenib cardiotoxicity increases mortality after myocardial infarction.

Duran, Jason M

Sorafenib cardiotoxicity increases mortality after myocardial infarction. [electronic resource] - Circulation research May 2014 - 1700-1712 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1524-4571

10.1161/CIRCRESAHA.114.303200 doi


Animals
Antineoplastic Agents--adverse effects
Apoptosis--drug effects
Cats
Cell Proliferation--drug effects
Cells, Cultured
Disease Models, Animal
Dose-Response Relationship, Drug
Heart--drug effects
In Vitro Techniques
Male
Metoprolol--pharmacology
Mice
Mice, Inbred C57BL
Myocardial Infarction--mortality
Myocytes, Cardiac--drug effects
Niacinamide--adverse effects
Phenylurea Compounds--adverse effects
Proto-Oncogene Proteins c-kit--drug effects
Sorafenib